19 February 2010 01:29 [Source: ICIS news]
SAN FRANCISCO (ICIS news)--There are two stages in the life cycle of pharmaceuticals where green chemistry can be most profitably implemented, according to a leader in the field.
Speaking Thursday at the InformexUSA exhibition in ?xml:namespace>
Drugs in Phase II and III clinical development present another opportunity, he said. The synthesis is not yet fixed by regulatory submissions, while the products themselves have a good chance of reaching market, he explained.
In either case, he added, the best place to start would probably be the synthetic step with the highest E-factor – that is, the step that produces the greatest waste per unit of product.
“You could do it in house, in collaboration with academic or research institutions, you could hire a professional company that is good at green chemistry, or you could do a combination of all,” he said.
Mehta suggested companies might begin by forming a group within the business focused specifically on promoting green chemistry. Such a group would combine environmentalism with entrepreneurship, a role he called “enviropreneurship”.
“If that kind of concept could be promoted, I think it would accelerate a lot the implementation of green chemistry,” he said.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections